Vote Scores

Home / Companies / Soleno Therapeutics, Inc. / 6 Jun 2024

Meeting · year to 30 June 202440 filers reporting

Soleno Therapeutics, Inc.: meeting of 6 Jun 2024

Votes reported on Form N-PX, item by item

40 Form N-PX filers reported votes at the Soleno Therapeutics, Inc. meeting of 6 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 81.5% of reported votes for; 9 filers withheld from or voted against at least one nominee.

53 vote records from 39 filers. 8 of the 39 filers that marked the item either way voted against management.

79.5% for0.0% against20.5% other20.5% against management39 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management13 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

53 vote records from 39 filers. 1 of the 39 filers that marked the item either way voted against management.

97.4% for2.6% against2.6% against management39 filers81.4% for18.6% against18.6% against management5,256,112 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

53 vote records from 39 filers. 31 of the 39 filers that marked the item either way voted against management.

20.5% for79.5% against79.5% against management39 filers37.7% for62.3% against62.3% against management5,134,887 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors3. Auditor
VanguardAbstain or withhold *For
BlackRock and iSharesForFor
FidelityForFor
DimensionalForFor
State Street and SPDRForFor
InvescoAbstain or withhold *For
EquitableForFor
Charles SchwabForFor
ProShares and ProFundsForFor
John Hancock and ManulifeForFor
PGIM and PrudentialAbstain or withhold *For
SEIForFor
T. Rowe PriceForFor
NationwideForFor
Victory CapitalForFor
Columbia ThreadneedleAbstain or withhold *For
PrincipalAbstain or withhold *For
Hartford FundsForFor
AllspringForFor
Janus HendersonForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Soleno Therapeutics, Inc. meeting?

40 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Soleno Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Soleno Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Soleno Therapeutics, Inc. with a meeting date within three days of 6 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.